Concepedia

Richard H. van der Jagt

RH

12

Publications

1.2K

Citations

12

H-Index

2005

Active since

Affiliations

Georgetown University(Current)

Ottawa Hospital

Stanford University

Cornell University

Washington University in St. Louis

Richard H. van der Jagt is an author at Georgetown University specializing in oncology, medicine, and pathology.

Top concepts

Publications per year

2005–2017

12

Publications

12

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

Katherine Robinson, Michael E. Williams, Richard H. van der Jagt et al. · Journal of Clinical Oncology · 2008 · 352 citations

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

Jonathan W. Friedberg, Philip Cohen, Ling Chen et al. · Journal of Clinical Oncology · 2008 · 298 citations · Full text

Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma

Brad S. Kahl, Nancy L. Bartlett, John P. Leonard et al. · Cancer · 2009 · 245 citations · Full text

Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

Bruce D. Cheson, Jonathan W. Friedberg, Brad S. Kahl et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 57 citations

, , +5

Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study

Christiane Pott, Eva Hoster, Britta Kehden et al. · Blood · 2016 · 45 citations

Rows per page

1–5 of 12